Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OptiNose, Inc. | 75,000 | reported | 06 Jun 2024 | tx 6+232,697 |
| AGIOS PHARMACEUTICALS, INC. | 2,120 | reported | 20 Jun 2024 | tx 6+54,976−1,976 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 2,120 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 11,774 | 0.00 USD | deriv |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,976 | 0.00 USD | |
| 13 Jun 2024 | EXERCISE | AGIOS PHARMACEUTICALS, INC. | 1,976 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | OptiNose, Inc. | 75,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 33,177 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | AGIOS PHARMACEUTICALS, INC. | 5,929 | 0.00 USD | deriv |
| 08 Jun 2023 | GRANT_AWARD | OptiNose, Inc. | 53,500 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | OptiNose, Inc. | 32,000 | 0.00 USD | deriv |
| 09 Jun 2021 | GRANT_AWARD | OptiNose, Inc. | 14,439 | 0.00 USD | deriv |
| 29 Jul 2020 | GRANT_AWARD | OptiNose, Inc. | 28,879 | 0.00 USD | deriv |
| 29 Jul 2020 | GRANT_AWARD | OptiNose, Inc. | 28,879 | 0.00 USD | deriv |